Cargando…
Simple clinical indicators for early psoriatic arthritis detection
BACKGROUND: Diagnosis of psoriatic arthritis (PsA), in a period of 12 months from the onset of the first articular episode, permits of identifying the early form defined as “early PsA”. The recognition of the disease in this phase leads to better outcome. The aim of this study was to identify peculi...
Autores principales: | Caso, Francesco, Costa, Luisa, Atteno, Mariangela, Del Puente, Antonio, Cantarini, Luca, Lubrano, Ennio, Scarpa, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320171/ https://www.ncbi.nlm.nih.gov/pubmed/25674484 http://dx.doi.org/10.1186/2193-1801-3-759 |
Ejemplares similares
-
The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection
por: Atteno, Mariangela, et al.
Publicado: (2014) -
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study
por: Scarpa, Raffaele, et al.
Publicado: (2011) -
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence
por: Costa, Luisa, et al.
Publicado: (2017) -
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018) -
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso, Rosario, et al.
Publicado: (2019)